Trades on 1 secondary market

Acesion Pharma

Acesion Pharma is a clinical-stage pharmaceutical company based in Frederiksberg, Denmark, developing novel therapies for atrial fibrillation (AF), the most common cardiac arrhythmia. The company pioneers small-molecule SK ion channel inhibition as a differentiated mechanism to treat AF safely and e

minimal 9.2 / 100 0 APIs View provider profile →
CompanyPharmaceuticalsBiotechnologyHealthcareLife SciencesCardiology

Acesion Pharma is an API provider whose private shares are listed on 1 secondary market: EquityZen.

Where It Trades

EZ EquityZen View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.